This Week on NeurologyLive® — February 21, 2022
Here's what is coming soon to NeurologyLive®.
Every week, the NeurologyLive® staff prepares this preview of what to expect from our coverage. This week on NeurologyLive®, there are a number of hot topics that we will be posting on the website. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!
Click through the slides below to see what you can expect from our team this week:
Click the image to view more, or click the arrows to see the next slide.
With the annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum taking place this week, Feb 24-26, the NeurologyLive® team will be on-site providing coverage straight from the conference floor. Our coverage will include in-depth conversations with experts and opinion leaders, as well as the latest on data readouts and sessions from the forum.
To catch up on the coverage of ACTRIMS, click here.
Click the image to view more, or click the arrows to see the next slide.
The MJH Life Sciences Medical World News streaming channel is on our midseason break for the next 2 weeks of Season 5. But, it is still always streaming 24/7, so make sure to check out the channel for new episodes, and catch up on-demand with your favorites before the new episodes go live—and now you can catch up on all new content from season 5!
NeurologyLive® contributes regularly to all of our show offerings, so there is plenty of specialty-focused and outside area conversations, as well as more lighthearted content for you to view.
To catch up and check out what's on the Medical World News channel now, or check out hundreds of episodes on-demand, click here.
The 58th episode of the NeurologyLive® Mind Moments™ podcast is set to premiere on Friday, February 25! The show will feature an exclusive conversation with Konstantin Karmazin, MD, chief medical officer, Prime PD, who will share insight into the digital wellness studio and its potential to improve care for patients with Parkinson disease and their physicians.
To listen and subscribe on your favorite podcast player, click here.
.png?w=1500&fit=max&auto=format)
Click the image to view more, or click the arrows to see the next slide.
The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, goes live on Wednesday, February 23. This week, it will feature a conversation with Andrea Synowiec, DO, FAAN, assistant director, Headache Center, Allegheny Health Network, who shared her perspective on the Allegheny Headache Registry, and what insight it may offer to clinicians caring for patients with headache and migraine.
To check out the prior NeuroVoices conversations, click here.
IN CASE YOU MISSED IT: The NeurologyLive® February 2022 issue went live last week! It includes feature articles by Adolfo Ramirez-Zamora, MD; Daniel Ackerman, MD, FAAN; and Crystal M. Proud, MD, and was led by guest editor-in-chief John Brandsema, MD. The issue covers topics in Parkinson disease, stroke, neuromuscular disorders, epilepsy, and much more—with a cover story on the ongoing shortage of neurologists.
To catch up on prior issues, click here.
Click the image to view more, or click the arrows to see the next slide.
IN CASE YOU MISSED IT: According to the National Institutes of Health’s clinical trials registry, more than 400 clinical trials of therapies designed to treat neurologic diseases are actively ongoing across phases 1 through 3 . Of those, more than 200 are in phase 3 development. Notably, many investigational therapies are addressing diseases with a high unmet clinical need, with either no currently available disease-modifying therapies or very limited options.
With so much activity in the clinical development pipeline, keeping up with the latest findings can sometimes be difficult. Here are 5 critical trials with expected data readouts in 2022 that NeurologyLive® will have its eye on.
.png?w=1500&fit=max&auto=format)
IN CASE YOU MISSED IT: The NeurologyLive® webinar, "Demystifying Multiple Sclerosis Etiology: The Role of Epstein-Barr Virus," is live! The series premiered on Friday, January 28, but is still FREE to register for and view!
New research supports a significant and causative relationship between infection with Epstein-Barr virus and the development of multiple sclerosis. This expert-led panel discussion, moderated by Scott Newsome, DO, will review the findings and discuss the implications for patients with multiple sclerosis, the health care providers who treat them, and the greater neurology community.
To catch up on the series, click here.